JP2002540137A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002540137A5 JP2002540137A5 JP2000607603A JP2000607603A JP2002540137A5 JP 2002540137 A5 JP2002540137 A5 JP 2002540137A5 JP 2000607603 A JP2000607603 A JP 2000607603A JP 2000607603 A JP2000607603 A JP 2000607603A JP 2002540137 A5 JP2002540137 A5 JP 2002540137A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- tumor
- group
- carbon atoms
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 32
- 239000002246 antineoplastic agent Substances 0.000 claims 18
- 206010028980 Neoplasm Diseases 0.000 claims 17
- 125000004432 carbon atom Chemical group C* 0.000 claims 14
- 229920000642 polymer Polymers 0.000 claims 10
- 125000001931 aliphatic group Chemical group 0.000 claims 9
- 229920002988 biodegradable polymer Polymers 0.000 claims 9
- 239000004621 biodegradable polymer Substances 0.000 claims 9
- 241000124008 Mammalia Species 0.000 claims 8
- 125000003545 alkoxy group Chemical group 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 7
- 206010006187 Breast cancer Diseases 0.000 claims 6
- 208000026310 Breast neoplasm Diseases 0.000 claims 6
- 229930012538 Paclitaxel Natural products 0.000 claims 6
- 239000000178 monomer Substances 0.000 claims 6
- 229960001592 paclitaxel Drugs 0.000 claims 6
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 6
- 230000002601 intratumoral effect Effects 0.000 claims 5
- 229940123237 Taxane Drugs 0.000 claims 4
- 125000002947 alkylene group Chemical group 0.000 claims 4
- 125000004104 aryloxy group Chemical group 0.000 claims 4
- 125000004470 heterocyclooxy group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- 125000002723 alicyclic group Chemical group 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 230000009036 growth inhibition Effects 0.000 claims 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 125000004825 2,2-dimethylpropylene group Chemical group [H]C([H])([H])C(C([H])([H])[H])(C([H])([H])[*:1])C([H])([H])[*:2] 0.000 claims 1
- 125000004810 2-methylpropylene group Chemical group [H]C([H])([H])C([H])(C([H])([H])[*:2])C([H])([H])[*:1] 0.000 claims 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- -1 and R 3 is H Chemical group 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 210000000038 chest Anatomy 0.000 claims 1
- 125000004956 cyclohexylene group Chemical group 0.000 claims 1
- 150000002009 diols Chemical class 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 150000002391 heterocyclic compounds Chemical class 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 1
- 239000004005 microsphere Substances 0.000 claims 1
- 210000003097 mucus Anatomy 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/276,866 | 1999-03-26 | ||
| US09/276,866 US6537585B1 (en) | 1999-03-26 | 1999-03-26 | Methods and compositions for treating solid tumors |
| PCT/US2000/007304 WO2000057852A2 (en) | 1999-03-26 | 2000-03-20 | Methods and compositions for treating solid tumors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011132938A Division JP2011219483A (ja) | 1999-03-26 | 2011-06-15 | 固型腫瘍の治療方法及び組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002540137A JP2002540137A (ja) | 2002-11-26 |
| JP2002540137A5 true JP2002540137A5 (enExample) | 2007-05-17 |
Family
ID=23058398
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000607603A Pending JP2002540137A (ja) | 1999-03-26 | 2000-03-20 | 固型腫瘍の治療方法及び組成物 |
| JP2011132938A Pending JP2011219483A (ja) | 1999-03-26 | 2011-06-15 | 固型腫瘍の治療方法及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011132938A Pending JP2011219483A (ja) | 1999-03-26 | 2011-06-15 | 固型腫瘍の治療方法及び組成物 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6537585B1 (enExample) |
| EP (1) | EP1185249B1 (enExample) |
| JP (2) | JP2002540137A (enExample) |
| KR (1) | KR20010111578A (enExample) |
| CN (1) | CN1367684A (enExample) |
| AT (1) | ATE306251T1 (enExample) |
| AU (1) | AU778279B2 (enExample) |
| BR (1) | BR0009213A (enExample) |
| CA (1) | CA2368621C (enExample) |
| CZ (1) | CZ20013260A3 (enExample) |
| DE (1) | DE60023138T2 (enExample) |
| HU (1) | HUP0201436A3 (enExample) |
| IL (1) | IL145492A0 (enExample) |
| NO (1) | NO20014662L (enExample) |
| PL (1) | PL351280A1 (enExample) |
| TR (1) | TR200102801T2 (enExample) |
| WO (1) | WO2000057852A2 (enExample) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6350464B1 (en) * | 1999-01-11 | 2002-02-26 | Guilford Pharmaceuticals, Inc. | Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
| US6537585B1 (en) | 1999-03-26 | 2003-03-25 | Guilford Pharmaceuticals, Inc. | Methods and compositions for treating solid tumors |
| AU2001270310A1 (en) * | 2000-07-07 | 2002-01-21 | Guilford Pharmaceuticals Inc. | Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same |
| AU2001280597A1 (en) * | 2000-07-17 | 2002-01-30 | Guilford Pharmaceuticals Inc. | Compositions for sustained release of analgesic agents, and methods of making and using the same |
| WO2002030472A2 (en) * | 2000-10-12 | 2002-04-18 | Guilford Pharmaceuticals, Inc. | Compositions for release of radiosensitizers, and methods of making and using the same |
| US20020141966A1 (en) * | 2000-11-16 | 2002-10-03 | Wenbin Dang | Compositions for treatment of malignant effusions, and methods of making and using the same |
| US20020081339A1 (en) * | 2000-12-22 | 2002-06-27 | Philippe Menei | Treatment of inoperable tumors by stereotactic injection of microspheres |
| WO2002092667A1 (en) * | 2001-05-14 | 2002-11-21 | Johns Hopkins Singapore Pte Ltd. | Biodegradable polyphosphates for controlled release of bioactive substances |
| US7417110B2 (en) * | 2001-05-14 | 2008-08-26 | Jun Wang | Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| AU2002354957A1 (en) * | 2001-07-19 | 2003-03-03 | Guilford Pharmaceuticals, Inc. | Biocompatible polymer containing composition for treatment of prostate cancers |
| US20030134892A1 (en) * | 2001-07-19 | 2003-07-17 | Wenbin Dang | Compositions for treatment of head and neck cancers, and methods of making and using the same |
| AU2003202255A1 (en) * | 2002-01-09 | 2003-07-30 | Guilford Pharmaceuticals, Inc. | Compositions for treatment of central nervous system neoplasms, and methods of making and using the same |
| AU2003216424A1 (en) * | 2002-02-25 | 2003-10-08 | Guilford Pharmaceuticals, Inc. | Phosphorus-containing compounds with polymeric chains, and methods of making and using the same |
| GB0223379D0 (en) * | 2002-10-09 | 2002-11-13 | Angiogene Pharm Ltd | Combination therapy |
| SI1677828T1 (sl) * | 2003-10-21 | 2013-04-30 | Psimedica Limited | Kompozitni material, ki vsebuje porozen polprevodnik impregniran z organsko substanco |
| US7795205B2 (en) * | 2004-04-12 | 2010-09-14 | Canyon Pharmaceuticals, Inc. | Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor |
| US20060024350A1 (en) * | 2004-06-24 | 2006-02-02 | Varner Signe E | Biodegradable ocular devices, methods and systems |
| WO2006002399A2 (en) * | 2004-06-24 | 2006-01-05 | Surmodics, Inc. | Biodegradable implantable medical devices, methods and systems |
| US20080124400A1 (en) * | 2004-06-24 | 2008-05-29 | Angiotech International Ag | Microparticles With High Loadings Of A Bioactive Agent |
| US20100092499A1 (en) * | 2004-12-06 | 2010-04-15 | Sciclone Pharmaceuticals, Inc. | Alpha Thymosin Peptides as Cancer Vaccine Adjuvants |
| HUE038768T2 (hu) | 2005-02-18 | 2018-11-28 | Abraxis Bioscience Llc | Terápiás szerek kombinációi, valamint beadásukra szolgáló módszerek, és kombinációs terápia |
| US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| CN101287507B (zh) * | 2005-08-12 | 2012-12-05 | 刘江 | 用于淋巴靶向的方法和装置 |
| GB0525864D0 (en) * | 2005-12-20 | 2006-02-01 | Novartis Ag | Organic compounds |
| EP3047860B1 (en) | 2006-07-20 | 2024-08-28 | OrbusNeich Medical Pte. Ltd. | Bioabsorbable polymeric composition for a medical device |
| US7959942B2 (en) | 2006-10-20 | 2011-06-14 | Orbusneich Medical, Inc. | Bioabsorbable medical device with coating |
| EP2073754A4 (en) | 2006-10-20 | 2012-09-26 | Orbusneich Medical Inc | BIOABSORBABLE POLYMER COMPOSITION AND MEDICAL DEVICE BACKGROUND |
| CN101390828B (zh) * | 2007-02-12 | 2010-06-09 | 济南康泉医药科技有限公司 | 同载抗代谢类药物和增效剂的抗癌组合物 |
| US11020363B2 (en) | 2009-05-29 | 2021-06-01 | Cydex Pharmaceuticals, Inc. | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same |
| ES2767880T3 (es) | 2009-05-29 | 2020-06-18 | Cydex Pharmaceuticals Inc | Composiciones inyectables de melfalán que comprenden un derivado de ciclodextrina y métodos de preparación y uso de las mismas |
| ES2362525B8 (es) * | 2009-10-08 | 2013-01-03 | Azurebio, S.L. | Formulación de medicamentos en forma de agujas percutaneas penetrantes. |
| TWI438009B (zh) * | 2010-02-19 | 2014-05-21 | Teikoku Pharma Usa Inc | 紫杉烷前－乳劑調配物及其製造與使用之方法 |
| US9393318B2 (en) | 2010-03-29 | 2016-07-19 | Abraxis Bioscience, Llc | Methods of treating cancer |
| BR112012024590A2 (pt) | 2010-03-29 | 2016-05-31 | Abraxis Bioscience Inc | métodos de reforço da liberação de fármaco e da eficácia de agentes terapêuticos |
| MX341082B (es) | 2010-05-03 | 2016-08-08 | Teikoku Pharma Usa Inc | Formulaciones de pro-emulsion de taxano no acuosas y metodos para hacer y usar las mismas. |
| KR20130088116A (ko) | 2010-06-04 | 2013-08-07 | 아브락시스 바이오사이언스, 엘엘씨 | 췌장암의 치료 방법 |
| JP6374388B2 (ja) * | 2012-09-21 | 2018-08-15 | インテンシティ セラピューティクス, インク.Intensity Therapeutics, Inc. | 癌の治療方法 |
| JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
| US9545447B2 (en) * | 2013-01-04 | 2017-01-17 | The Texas A&M University System | Polymer-drug systems |
| US10751319B2 (en) | 2015-06-04 | 2020-08-25 | Crititech, Inc. | Collection device and methods for use |
| EP3439635B1 (en) | 2016-04-04 | 2020-12-09 | Crititech, Inc. | Formulations for solid tumor treatment |
| SG10201913649TA (en) | 2017-06-09 | 2020-03-30 | Crititech Inc | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
| KR102303762B1 (ko) | 2017-06-14 | 2021-09-23 | 크리티테크, 인크. | 폐 장애의 치료 방법 |
| BR112020005814A2 (pt) | 2017-10-03 | 2020-09-24 | Crititech, Inc. | administração local de partículas antineoplásicas em combinação com administração sistêmica de agentes imunoterapêuticos para o tratamento de câncer |
| WO2020072090A1 (en) * | 2018-10-03 | 2020-04-09 | Crititech, Inc. | Use of antineoplastic agents to stimulate the immune system for production of tertiary lymphoid structures (tls) |
| KR20210078505A (ko) * | 2018-10-16 | 2021-06-28 | 유에스 나노 푸드 앤 드럭 인코포레이티드 | 종양내 주사 제형 |
| PH12022552732A1 (en) | 2020-04-13 | 2024-03-25 | US Nano Food & Drug INC | Basic chemotherapeutic intratumour injection formulation |
| GB2623319A (en) | 2022-10-11 | 2024-04-17 | Af Chempharm Ltd | Method of synthesis of chloro-oxo-dioxaphospholane oxides and derivates |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3271329A (en) | 1958-09-19 | 1966-09-06 | Eastman Kodak Co | Method for producing polymers derived from phosphites and glycols |
| US3442982A (en) | 1965-10-15 | 1969-05-06 | Weston Chemical Corp | Polyphosphites of 2,2-dimethyl-3-hydroxypropyl - 2 - dimethyl - 3-hydroxypropionate |
| FR2219193B1 (enExample) | 1973-02-28 | 1976-05-21 | Rhone Poulenc Sa | |
| US3932566A (en) | 1974-09-16 | 1976-01-13 | Celanese Corporation | Phosphonate polymers |
| US4100354A (en) | 1976-08-05 | 1978-07-11 | Owens-Corning Fiberglass Corporation | Terephthalate ester polyols |
| US4259222A (en) | 1978-08-16 | 1981-03-31 | Basf Wyandotte Corporation | Linear saturated polyesters of phosphoric acid and halogenated diols as flame-retardant additives and coatings |
| DE2925206A1 (de) | 1979-06-22 | 1981-01-29 | Bayer Ag | Aromatische polyesterphosphonate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung thermoplastischer formkoerper |
| FR2498612A1 (fr) | 1981-01-26 | 1982-07-30 | Peters Ligatures | Nouveaux polymeres insolubles a biodegradabilite reglable a volonte, leurs procedes de preparation et leur application en tant que biomateriaux |
| US4757128A (en) | 1986-08-01 | 1988-07-12 | Massachusetts Institute Of Technology | High molecular weight polyanhydride and preparation thereof |
| US4474937A (en) | 1983-10-03 | 1984-10-02 | The Dow Chemical Company | Phosphorus-modified polyestercarbonate resins |
| US4481353A (en) | 1983-10-07 | 1984-11-06 | The Children's Medical Center Corporation | Bioresorbable polyesters and polyester composites |
| US4746462A (en) | 1985-02-21 | 1988-05-24 | Dainichiseika Color & Chemicals Mfg. Co., Ltd. | Phosphoric ester compound |
| US4789724A (en) | 1986-10-17 | 1988-12-06 | Massachusetts Institute Of Technology | Preparation of anhydride copolymers |
| US4978332A (en) | 1987-09-28 | 1990-12-18 | Matrix Pharmaceutical, Inc. | Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas |
| US5194581A (en) | 1989-03-09 | 1993-03-16 | Leong Kam W | Biodegradable poly(phosphoesters) |
| US5256765A (en) | 1989-03-09 | 1993-10-26 | The Johns Hopkins University School Of Medicine | Biodegradable poly(phosphate esters) |
| US5162115A (en) | 1989-05-09 | 1992-11-10 | Pietronigro Dennis D | Antineoplastic solution and method for treating neoplasms |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| NO302481B1 (no) | 1990-10-16 | 1998-03-09 | Takeda Chemical Industries Ltd | Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring |
| US5429634A (en) | 1993-09-09 | 1995-07-04 | Pdt Systems | Biogenic implant for drug delivery and method |
| JPH08511418A (ja) | 1993-04-19 | 1996-12-03 | メディソーブ・テクノロジーズ・インターナショナル・リミテッド・パートナーシップ | 生分解性極微粒子からのアンチセンスオリゴデオキシリボヌクレオチドの徐放運搬による長期作用のある処置 |
| US5886026A (en) | 1993-07-19 | 1999-03-23 | Angiotech Pharmaceuticals Inc. | Anti-angiogenic compositions and methods of use |
| DE69431071T2 (de) | 1993-12-29 | 2003-03-20 | Matrix Pharma | Zusammensetzung für lokale freigabe von zytostatika |
| DE4404365A1 (de) | 1994-02-11 | 1995-08-17 | Cassella Ag | Phosphin- und phosphonsäuregruppenhaltige Polykondensate |
| US5626862A (en) | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| US5637085A (en) | 1995-11-20 | 1997-06-10 | Cardinale; Robert M. | Method of cancer tumor treatment by slow release delivery of 1,2,4-benzotriazine oxides to tumor site |
| DE69731623D1 (de) | 1996-04-23 | 2004-12-23 | Ipsen Mfg Ireland Ltd | Saure Polymilchsäure Polymere |
| US5993856A (en) | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
| AU744095B2 (en) | 1997-03-27 | 2002-02-14 | Baker Norton Pharmaceuticals, Inc. | Methods and compositions for treatment of ovarian cancer |
| UA54505C2 (uk) | 1997-04-03 | 2003-03-17 | Гілфорд Фармасьютікалз Інк. | Полімери, що біологічно розкладаються, зшиті фосфатами, композиції, вироби і способи для їх виготовлення і використання |
| IL132120A0 (en) * | 1997-04-03 | 2001-03-19 | Guilford Pharm Inc | Biodegradable terephthalate polyester-poly (phosphate) polymers compositions articles and methods for making and using the same |
| US5912225A (en) | 1997-04-14 | 1999-06-15 | Johns Hopkins Univ. School Of Medicine | Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same |
| EP0980269A1 (en) | 1997-04-30 | 2000-02-23 | Guilford Pharmaceuticals Inc. | Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the same |
| EP0991699B1 (en) * | 1997-06-18 | 2002-04-24 | Guilford Pharmaceuticals Inc. | Two-stage solution polymerization of high molecular weight poly(phosphoesters) |
| US6028163A (en) * | 1997-06-27 | 2000-02-22 | Guilford Pharmaceuticals Inc. | Solution polymerization of high molecular weight poly(phosphoesters) in toluene |
| US6419709B1 (en) * | 1998-10-02 | 2002-07-16 | Guilford Pharmaceuticals, Inc. | Biodegradable terephthalate polyester-poly(Phosphite) compositions, articles, and methods of using the same |
| US6153212A (en) * | 1998-10-02 | 2000-11-28 | Guilford Pharmaceuticals Inc. | Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same |
| JP2002526396A (ja) | 1998-10-02 | 2002-08-20 | ギルフォード ファーマシュウティカルズ インコーポレイテッド | 生分解性テレフタレートポリエステル−ポリホスホネートとポリエステル−ポリホスファイトの組成物、物品、及びそれらの使用方法 |
| US6350464B1 (en) | 1999-01-11 | 2002-02-26 | Guilford Pharmaceuticals, Inc. | Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
| US6537585B1 (en) | 1999-03-26 | 2003-03-25 | Guilford Pharmaceuticals, Inc. | Methods and compositions for treating solid tumors |
| CA2369740A1 (en) | 1999-04-22 | 2000-11-02 | American Biosciences, Inc. | Long term administration of pharmacologically active agents |
| AU2001270310A1 (en) | 2000-07-07 | 2002-01-21 | Guilford Pharmaceuticals Inc. | Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same |
| AU2001280597A1 (en) * | 2000-07-17 | 2002-01-30 | Guilford Pharmaceuticals Inc. | Compositions for sustained release of analgesic agents, and methods of making and using the same |
| WO2002030472A2 (en) * | 2000-10-12 | 2002-04-18 | Guilford Pharmaceuticals, Inc. | Compositions for release of radiosensitizers, and methods of making and using the same |
| US20030134892A1 (en) * | 2001-07-19 | 2003-07-17 | Wenbin Dang | Compositions for treatment of head and neck cancers, and methods of making and using the same |
| AU2002354957A1 (en) * | 2001-07-19 | 2003-03-03 | Guilford Pharmaceuticals, Inc. | Biocompatible polymer containing composition for treatment of prostate cancers |
-
1999
- 1999-03-26 US US09/276,866 patent/US6537585B1/en not_active Expired - Fee Related
-
2000
- 2000-03-20 IL IL14549200A patent/IL145492A0/xx unknown
- 2000-03-20 DE DE60023138T patent/DE60023138T2/de not_active Expired - Lifetime
- 2000-03-20 PL PL00351280A patent/PL351280A1/xx not_active Application Discontinuation
- 2000-03-20 CA CA2368621A patent/CA2368621C/en not_active Expired - Fee Related
- 2000-03-20 WO PCT/US2000/007304 patent/WO2000057852A2/en not_active Ceased
- 2000-03-20 AU AU37625/00A patent/AU778279B2/en not_active Ceased
- 2000-03-20 EP EP00916536A patent/EP1185249B1/en not_active Expired - Lifetime
- 2000-03-20 CZ CZ20013260A patent/CZ20013260A3/cs unknown
- 2000-03-20 TR TR2001/02801T patent/TR200102801T2/xx unknown
- 2000-03-20 HU HU0201436A patent/HUP0201436A3/hu unknown
- 2000-03-20 BR BR0009213-4A patent/BR0009213A/pt not_active Application Discontinuation
- 2000-03-20 CN CN00806972A patent/CN1367684A/zh active Pending
- 2000-03-20 AT AT00916536T patent/ATE306251T1/de not_active IP Right Cessation
- 2000-03-20 KR KR1020017012256A patent/KR20010111578A/ko not_active Withdrawn
- 2000-03-20 JP JP2000607603A patent/JP2002540137A/ja active Pending
-
2001
- 2001-09-25 NO NO20014662A patent/NO20014662L/no not_active Application Discontinuation
-
2003
- 2003-02-03 US US10/357,292 patent/US7101568B2/en not_active Expired - Fee Related
-
2011
- 2011-06-15 JP JP2011132938A patent/JP2011219483A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002540137A5 (enExample) | ||
| CA2368621A1 (en) | Methods and compositions for treating solid tumors | |
| US12017989B2 (en) | Controlled release pharmaceutical formulations | |
| US5622986A (en) | 2'-and/or 7-substituted taxanes | |
| JP2004537517A5 (enExample) | ||
| US5801191A (en) | Taxoids | |
| CN109810092B (zh) | 含有一氧化氮供体的环状碳酸酯单体及其制备和应用 | |
| Feng et al. | Synthesis and evaluation of water-soluble paclitaxel prodrugs | |
| CA2359109A1 (en) | Methods for treating ovarian cancer, poly(phosphoester) compositions, and biodegradable articles for same | |
| JP2020122016A5 (enExample) | ||
| US5547981A (en) | Taxol-7-carbazates | |
| JP2006524702A5 (enExample) | ||
| KR101793483B1 (ko) | 2 유황 5원환 관능기를 포함하는 환상 카르보네이트 모노머 및 이의 제조방법 | |
| CN101569747B (zh) | 一种聚乙二醇为载体的紫杉醇的前药制备方法 | |
| CN1895676B (zh) | 聚乙二醇为载体的紫杉醇或多烯紫杉醇的前药 | |
| CN102512683A (zh) | 一种高分子基因药物载体及其制备方法和在制备抗肿瘤药物中的应用 | |
| CN108815536B (zh) | 一种具有pH和双重氧化还原响应性的药物递送材料及其制备方法和应用 | |
| EP1289976A1 (en) | Novel paclitaxel derivatives for the treatment of cancer | |
| CN113952464B (zh) | 含酮羰基的疏水性抗肿瘤药物及其应用 | |
| Rodríguez-Prieto et al. | Synthesis of degradable cationic carbosilane dendrimers based on Si–O or ester bonds | |
| CN1395571A (zh) | 具有抗肿瘤和抗血管生成活性的半合成紫杉烷 | |
| RU2001129096A (ru) | Способы и составы для лечения солидных опухолей | |
| CN103263675B (zh) | 一种聚ε-己内酯负载的抗肿瘤前药及其制备方法 | |
| CN103816548A (zh) | 靶向亲水性聚合物-雷公藤甲素结合物 | |
| CN116813674B (zh) | 一种唾液酸-喜树碱前药Sia-ss-CPT及其制备方法与应用 |